Research & Development



  我就不明白,這些人直到現在還認為做生意的商賈是賤業,真是不可思議。”   所以,雲氏現在已經是一個很籠統的稱呼,只要是雲氏僕婦,即便是已經離開了雲氏,也習慣性的在家門口標上雲氏別院這樣的門頭。伊人在线猫   上林苑也有窮人,可是,上林苑的窮人跟這里的窮人根本就是兩回事。大香蕉网伊人在线4   就如師傅所言——實踐才是檢驗真理的唯一法門。   甦武笑了,看著蒙查的胯下道︰“好家伙!與驢馬無異!”五月婷婷久久大香蕉   而不是自己生根發芽,即便是一棵梨樹五年之後才能結果,我們的時間太少,消耗不起。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo